Glenn Pierce

Director, Global Blood Therapeutics, Inc.

Companies

Voyager Therapeutics (United States)Board member Jan 5, 2017 to now¹
Global Blood Therapeutics, Inc.Board member Feb 10, 2016 to Oct 6, 2022²
Voyager Therapeutics (United States)Interim CSO Jun 4, 2021 to Jan 18, 2022³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Voyager Therapeutics (United States) VYGR21,788 shares⁴$44.7K at $2.05Jul 18, 2022
Global Blood Therapeutics, Inc.0 shares⁵Oct 5, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

Oct 5, 2022Returned to company 26,437 shares of Global Blood Therapeutics, Inc.⁵
Jul 14, 2022Sold 9,512 shares at $6.70 of Voyager Therapeutics (United States)⁴
Jun 14, 2022Exercised options 3,600 shares of Global Blood Therapeutics, Inc.⁶
Jan 13, 2022Granted 26,300 shares of Voyager Therapeutics (United States)⁷

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARVoyager Therapeutics (United States), Board member
2
SEC EDGARGlobal Blood Therapeutics, Inc., Board member
3
SEC EDGARVoyager Therapeutics (United States), Interim CSO
4
SEC EDGARVoyager Therapeutics (United States) shares after the filing of Jul 18, 2022
5
SEC EDGARGlobal Blood Therapeutics, Inc. shares after the filing of Oct 5, 2022
6
SEC EDGARForm 4 filed Jun 16, 2022
7
SEC EDGARForm 4 filed Jan 18, 2022